Furthermore, in lung tissues, transcriptome-wide association demonstrated that predicted low levels of CXCR6 together with low expression of CCCR3 and high expression of CCR2 are associated with severe COVID-19 (defined as admission to critical care) vs. controls [117,154]. This evidence concerns the gene CCR2 and COVID-19.